NCT01827605 2023-12-14
A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)
Fondazione Italiana Linfomi - ETS
Phase 3 Unknown
Clinical Trials
4 trialsNCT00397800 2012-08-28
Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma
Technical University of Munich
Phase 1/2 Unknown
NCT00772655 2012-08-02
Zevalin® First Line in Follicular Lymphoma
Charite University, Berlin, Germany
Phase 2 Unknown
NCT00722930 2008-07-28
GOTEL-FL1LC
Grupo Oncológico para el Tratamiento y el Estudio de los Linfomas
Phase 2 Unknown